IL17A and arthritic joint disease: A recent study confirmed that the combined blockade of TNFα and IL-17A is more effective in inhibiting cytokine, chemokine, and matrix enzyme responses from human mesenchymal cells and in blocking tissue destruction associated with a mouse model of arthritis (45).